We have known that many advanced cancer patients are refused to treat more after standard chemotherapy at Shizuoka Cancer Center, even if they could be estimated to recover with other treatments including thalidomide and celecoxib. They are ordered to select palliative care even though they have a chance to be saved with other treatments.

Please help Japanese advanced cancer patients save their lives from Shizuoka Concentration Cancer Center (President Ken Yamaguchi). They have to die with the cease of respiration after injections of overdose morphine hearing the stream sound of high volume oxygen.

I synthesized highly purified thalidomide in 1999 and treated the patients since 2000. But we are ordered to recall every capsule from the Ministry of Health, Labor and Welfare in 2002. The reason is thalidomide is dangerous medicine. In 2005, we submitted a clinical trial, using thalidomide, celecoxib and low dose gemcitabine for pancreatic cancer, to the Ministry of Health, Labor and Welfare. But the clinical trial for multiple myeloma of Fujimoto Pharmaceutical Corporation with poor medical knowledge was approved by illegal transaction between bureaucrats and the Corporation. Fujimoto Pharmaceutical Corporation should conduct various efficient clinical trials to help the patients with advanced and metastatic cancers.